Profil Pasien Tinea Korporis di Unit Rawat Jalan Kulit dan Kelamin RSUD Dr. Soetomo Surabaya pada Tahun 2014-2015
Background: The prevalence of dermatophytosis in Indonesia is about 52% of all fungal infection which is dominated by tinea cruris and tinea corporis. The total case of tinea corporis is high, but the information about its risk factor and characteristic is still limited. Objective: This study wa...
Saved in:
Main Author: | |
---|---|
Format: | Theses and Dissertations NonPeerReviewed |
Language: | English English |
Published: |
2017
|
Subjects: | |
Online Access: | http://repository.unair.ac.id/67611/1/abstrak.pdf http://repository.unair.ac.id/67611/2/full%20text.pdf http://repository.unair.ac.id/67611/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Airlangga |
Language: | English English |
Summary: | Background: The prevalence of dermatophytosis in Indonesia is about 52% of all
fungal infection which is dominated by tinea cruris and tinea corporis. The total case
of tinea corporis is high, but the information about its risk factor and characteristic is
still limited.
Objective: This study was undertaken to describe the clinical profile of tinea corporis
patients in outpatient clinic of dermatovenereology Dr. Soetomo General Hospital
Surabaya.
Methods: A retrospective research with cross-sectional method of tinea corporis
patients’ medical record at mycology division - outpatient clinic of
dermatovenereology of Dr. Soetomo General Hospital Surabaya from 1 January 2014
to 31 December 2015 with 339 samples.
Results: Tinea corporis was common in female (58,11%). It was dominated by postpubertal
group between fourth and fifth decade of age. Tinea cruris was the most
comorbid infection in this case. Based on the laboratory examination, there were
85,25% patients showed positive result for hyphae, 72,57% patients showed negative
result for blastospore on KOH test and 64,31% patients showed negative result for
Wood’s lamp examination. There were 54,87% patients who had oral griseofulvin as
the treatment and 86,30% patients showed the improvement in two weeks from the
first treatment. |
---|